SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ashish Goyal, John M. Murray, Effect of interferon-alpha therapy on hepatitis D virus, Hepatology, 2015, 61, 5
  2. 2
    Avidan U. Neumann, Sandra Phillips, Idit Levine, Samreen Ijaz, Harel Dahari, Rachel Eren, Shlomo Dagan, Nikolai V. Naoumov, Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells, Hepatology, 2010, 52, 3
  3. 3
    Jin Yang, Ting Cai, Guo-Qiang Lou, Anti-hepatitis B virus treatment guided by long-term virus kinetics stepwise tracing, Journal of Gastroenterology and Hepatology, 2009, 24, 6
  4. 4
    Harel Dahari, Scott J. Cotler, Thomas J. Layden, Alan S. Perelson, Hepatitis B virus clearance rate estimates, Hepatology, 2009, 49, 5
  5. 5
    Sharon R. Lewin, Ruy M. Ribeiro, Anchalee Avihingsanon, Scott Bowden, Gail Matthews, Pip Marks, Stephen A. Locarnini, Kiat Ruxrungtham, Alan S. Perelson, Gregory J. Dore, Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy, Hepatology, 2009, 49, 4
  6. 6
    Nobukazu Yuki, Takayuki Nagaoka, Kazuhiko Nukui, Masao Omura, Kazumasa Hikiji, Michio Kato, Adding interferon to lamivudine enhances the early virologic response and reversion of the precore mutation in difficult-to-treat HBV infection, Journal of Gastroenterology, 2008, 43, 6, 457

    CrossRef

  7. 7
    Vana Sypsa, Angelos Hatzakis, Modelling of viral dynamics in hepatitis B and hepatitis C clinical trials, Statistics in Medicine, 2008, 27, 30
  8. 8
    Maurizia Rossana Brunetto, Piero Colombatto, Ferruccio Bonino, Personalized therapy in chronic viral hepatitis, Molecular Aspects of Medicine, 2008, 29, 1-2, 103

    CrossRef

  9. 9
    I-Chin Wu, Nan-Haw Chow, Pin-Nan Cheng, Wen-Chun Liu, Kung-Chia Young, Wei-Lun Chang, Chi-Yi Chen, Kuo-Chih Tseng, Ting-Tsung Chang, Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B, Journal of Medical Virology, 2007, 79, 6
  10. 10
    Man-Fung Yuen, Ching-Lung Lai, Combination Therapy for Chronic Hepatitis B: Simultaneous or Sequential?, The American Journal of Gastroenterology, 2007, 102, 1, 105

    CrossRef

  11. 11
    Shiv Kumar Sarin, Ajit Sood, Manoj Kumar, Anil Arora, Deepak Amrapurkar, Barjesh Chander Sharma, Ashokananda Konar, Yogesh Kumar Chawla, Rajendra Kumar Jain, Vijay Nanda, Arun Kumar, Syed Hissar, Piramal Lavate, Deepak Lahoti, Effect of Lowering HBV DNA Levels by Initial Antiviral Therapy Before Adding Immunomodulator on Treatment of Chronic Hepatitis B, The American Journal of Gastroenterology, 2007, 102, 1, 96

    CrossRef

  12. 12
    Martijn J. ter Borg, Monika van Zonneveld, Stefan Zeuzem, Hakan Senturk, Ulus S. Akarca, Christopher Simon, Bettina E. Hansen, Bart L. Haagmans, Robert A. de Man, Solko W. Schalm, Harry L.A. Janssen, Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response, Hepatology, 2006, 44, 3
  13. 13
    Takeshi Okanoue, Masahito Minami, Update of research and management of hepatitis B, Journal of Gastroenterology, 2006, 41, 2, 107

    CrossRef

  14. 14
    Avidan U. Neumann, Hepatitis B viral kinetics: A dynamic puzzle still to be resolved, Hepatology, 2005, 42, 2